Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
27 Jul 2016
UCB continues to deliver on its growth strategy
Read More
22 Jul 2016
UCB and Amgen submit biologics license application for Romosozumab to the U.S. FDA
Read More
4 Jul 2016
UCB and Daiichi Sankyo announce Japanese approval of lacosamide (brand name VIMPAT®) as adjunctive therapy in the treatment of partial-onset seizures in adult patients with epilepsy
Read More
9 Jun 2016
UCB’s bimekizumab demonstrates positive results in early development in patients with psoriatic arthritis
Read More
7 Jun 2016
UCB commitment to addressing real world patient needs on display at the Annual European Congress of Rheumatology (EULAR 2016)
Read More
30 May 2016
BRIVIACT® now available in U.S. pharmacies for epilepsy patients living with partial-onset seizures
Read More
29 May 2016
Positive VIMPAT® (lacosamide) monotherapy Phase III trial results presented at European Academy of Neurology Congress
Read More
28 Apr 2016
UCB's shareholder meeting today
Read More
25 Apr 2016
UCB First Three Months Interim Report 2016:
Read More
1 Apr 2016
Amgen and UCB present positive data at ENDO 2016 comparing romosozumab with teriparatide
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
38
Page
39
Page
40
Page
41
Current page
42
Page
43
Page
44
Page
45
Page
46
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss